Cambrex
CBM | US
Overview
Corporate Details
- ISIN(s):
- US1320111073
- LEI:
- 4Q9DLX2VIFGJMOYJ4Y35
- Country:
- United States of America
- Address:
- N/A
- Website:
- https://www.cambrex.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
Automate Your Workflow. Get a real-time feed of all Cambrex filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Cambrex
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cambrex via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea
007460
South Korea
007460
South Korea
293780
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea
291650
South Korea
291650
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
United States of America
APM
United States of America
APM
Develops oral film drugs for CNS disorders and severe allergies.
United States of America
AQST
United States of America
AQST
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
United States of America
ABUS
United States of America
ABUS
Engineering controllable cell therapies for cancer and autoimmune diseases.
United States of America
ACLX
United States of America
ACLX
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway
ABS
Norway
ABS
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway
AZT
Norway
AZT
Develops mRNA therapeutics and vaccines for rare respiratory, liver, and infectious diseases.
United States of America
ARCT
United States of America
ARCT